Encontrados 2 documentos, a visualizar página 1 de 1
Biomarkers in the assessment of therapies for familial amyloidotic polyneuropathy
MACEDO, B.; BATISTA, A.R.; DO AMARAL, J.B.; SARAIVA, M.J.Mol Med. 2007 Nov-Dec;13(11-12):584-91. Biomarkers in the assessment of therapies for familial amyloidotic polyneuropathy. Macedo B, Batista AR, do Amaral JB, Saraiva MJ. SourceMolecular Neurobiology, Instituto de Biologia Molecular e Celular, Porto, Portugal. Abstract The identification of specific biomarkers provides opportunities to develop early diagnostic parameters, monitor disease progression, and test ...
Activation of ERK1/2 MAP kinases in familial amyloidotic polyneuropathy
MONTEIRO, F.A.; SOUSA, M.M.; CARDOSO, I.; DO AMARAL, J.B.; GUIMARAES, A.; SARAIVA, M.J.J Neurochem. 2006 Apr;97(1):151-61. Epub 2006 Mar 3. Activation of ERK1/2 MAP kinases in familial amyloidotic polyneuropathy. Monteiro FA, Sousa MM, Cardoso I, do Amaral JB, Guimarães A, Saraiva MJ. Molecular Neurobiology, Instituto de Biologia Celular e Molecular, ICBAS, University of Porto, and Estomatology, Maxillofacial Surgery, Hospital Geral de Santo António, Portugal. Abstract Familial amyloidotic pol...
| Financiadores do RCAAP | |||||||
|
|
|
|
|
|
||